attracts attention from medical professionals mainly for its intrinsic resistance to fluconazole and the limited number of drugs available to treat vulvovaginal candidiasis. Miltefosine was demonstrated to have good antifungal activity both and . Here, we determined the susceptibility profiles of 57 clinical isolates from vulvovaginal candidiasis patients and assessed the antifungal activity of miltefosine against .